quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:19:04·617d
INSIDERFiling
TenX Keane Acquisition logo

SEC Form 3 filed by new insider Webb Carol

TENK· TenX Keane Acquisition
Finance
Original source

Companies

  • TENK
    TenX Keane Acquisition
    Finance

Related

  • 13D/G616d
    Amendment: SEC Form SC 13D/A filed by TenX Keane Acquisition
  • INSIDER617d
    SEC Form 4 filed by Director Dutia Suren G
  • INSIDER617d
    SEC Form 4 filed by Director Holubiak Myron Z
  • INSIDER617d
    SEC Form 4 filed by Chief Medical Officer Czuczman Myron
  • INSIDER617d
    SEC Form 4 filed by Chief Executive Officer Mazur Leonard L
  • INSIDER617d
    SEC Form 4 filed by Chief Financial Officer Bartushak Jaime
  • INSIDER617d
    SEC Form 4 filed by Director Mcgrath Dennis M
  • INSIDER617d
    SEC Form 4 filed by Large owner Citius Pharmaceuticals, Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022